about
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (N...
Read More
11.65
-0.35
(-2.92%)
59,671
XNAS Volume
XNAS 20 Jul, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Eloxx Pharma is scheduled for today, for the purpose of Eloxx Pharmaceuticals Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Eloxx Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..